These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22670488)

  • 21. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention.
    Friedman LC; Everett TE; Peterson L; Ogbonnaya KI; Mendizabal V
    J Cancer Educ; 2001; 16(2):85-8. PubMed ID: 11440068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colon cancer screening in a large, multispecialty group practice.
    Hatfield AK; Bozinovich MA; Steiner JA; Alster JM; Imrey PB
    Prog Clin Biol Res; 1984; 156():283-94. PubMed ID: 6473437
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
    Morini S; Manurita L; Stroppa I; Bassi O
    Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet for fecal occult blood test screening: help or harm?
    Fletcher RH
    Eff Clin Pract; 2001; 4(4):180-2. PubMed ID: 11525106
    [No Abstract]   [Full Text] [Related]  

  • 27. An evaluation of fecal occult blood screening in automated multiphasic health testing and services.
    Nishikawa A; Okuda T; Kubota I; Azuma H; Tanaka T; Koyasu T; Kumazaki N; Iwata H; Tanaka T; Kato K
    Jpn J Clin Oncol; 1987 Jun; 17(2):107-12. PubMed ID: 3613137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to Achieve Colon Cancer Screening in Average Risk Population: A Review of Different Screening Options.
    Whatley J; Sones JQ
    J Miss State Med Assoc; 2016 Mar; 57(3):82-7. PubMed ID: 27209810
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests.
    Miyoshi H; Ohshiba S; Asada S; Hirata I; Uchida K
    Am J Gastroenterol; 1992 Jan; 87(1):67-73. PubMed ID: 1728128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon cancer detection using guaiac screening.
    Withers JN; James WC
    Hawaii Med J; 1978 Dec; 37(12):363-5. PubMed ID: 738878
    [No Abstract]   [Full Text] [Related]  

  • 33. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
    Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
    Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoquant--an approach to screening for fecal occult blood.
    McGill DB; Ahlquist DA
    Prog Clin Biol Res; 1985; 186():45-56. PubMed ID: 4034605
    [No Abstract]   [Full Text] [Related]  

  • 36. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemoccult test. Results in systematic health evaluation of the Parisian Region Central Primary Disease Insurance Desk].
    Champeau J; Freche C; Jacquier L
    Med Chir Dig; 1978; 7(5):423-4. PubMed ID: 723320
    [No Abstract]   [Full Text] [Related]  

  • 38. Colorectal cancer screening. Faecal occult blood tests.
    McDonald C
    Aust Fam Physician; 1985 Apr; 14(4):273, 276-7. PubMed ID: 4015528
    [No Abstract]   [Full Text] [Related]  

  • 39. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Population screening for colon and rectum cancer using the Hemoccult test].
    van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(43):1967-9. PubMed ID: 7177204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.